B
휴온스
243070KOSDAQ55.0 / 100
Reference Date: 2026-10-23
Financial Score31.5 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure7.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 12.8% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Hoonswell, established in 1965, is a pharmaceutical company operating in specialty drugs, beauty & wellness, and contract manufacturing (CMO). Key products include local anesthetics, functional food supplements, and medical devices, with exports to the U.S. via FDA approval. The company expanded its global presence by launching its second plant in Cheongju in 2024.
Number of Employees
1,087people
Average Salary
58.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
4.96Industry Average 15.008.0Point
Half of industry avg (excellent)
PBR
0.50Industry Average 1.207.0Point
Half of industry avg (excellent)
ROE
11.04Industry Average 8.004.0Point
In line with industry avg
Debt Ratio
22.82Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20254.5 / 10 points
Revenue Growth Rate
2.0 / 3
Avg ▲6.0% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼7.1% (2-year basis)
ROE Trend
2.5 / 4
Avg ROE 12.0% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (1%, downtrend)
Current 17,480Won52-week high 38,20052-week low 17,250
1-month return1.0Point
1m -12.82% (falling)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
1 totalPositive 0Neutral 0Negative 1
- Negative불성실공시법인미지정 (지정유예)2026-10-21